WS, Z., V, A., FG, D., MR, G., N, S., N, C., . . . A, L. (2026). Tumor Purity as a Prognostic and Predictive Biomarker of Postoperative Radiation Therapy Outcomes in Stage IIIA-N2 Non-Small Cell Lung Cancer: A Transcriptomic Analysis From the Lung ART Trial. International journal of radiation oncology, biology, physics. https://doi.org/10.1016/j.ijrobp.2026.03.006
Chicago Style (17th ed.) CitationWS, Zrafi, et al. "Tumor Purity as a Prognostic and Predictive Biomarker of Postoperative Radiation Therapy Outcomes in Stage IIIA-N2 Non-Small Cell Lung Cancer: A Transcriptomic Analysis From the Lung ART Trial." International Journal of Radiation Oncology, Biology, Physics 2026. https://doi.org/10.1016/j.ijrobp.2026.03.006.
MLA (9th ed.) CitationWS, Zrafi, et al. "Tumor Purity as a Prognostic and Predictive Biomarker of Postoperative Radiation Therapy Outcomes in Stage IIIA-N2 Non-Small Cell Lung Cancer: A Transcriptomic Analysis From the Lung ART Trial." International Journal of Radiation Oncology, Biology, Physics, 2026, https://doi.org/10.1016/j.ijrobp.2026.03.006.
